- Report
- January 2024
- 199 Pages
Global
From €4016EUR$4,450USD£3,489GBP
- Report
- February 2026
- 150 Pages
India
From €4377EUR$4,850USD£3,803GBP
- Report
- February 2026
- 173 Pages
Canada
From €4377EUR$4,850USD£3,803GBP
- Report
- February 2026
- 182 Pages
China
From €4377EUR$4,850USD£3,803GBP
- Report
- February 2026
- 175 Pages
India
From €4377EUR$4,850USD£3,803GBP
- Report
- December 2025
- 150 Pages
Germany
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 150 Pages
India
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 150 Pages
Japan
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 150 Pages
Japan
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 150 Pages
Japan
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 150 Pages
China
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 150 Pages
China
From €4377EUR$4,850USD£3,803GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- December 2024
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- April 2023
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3249EUR$3,600USD£2,823GBP

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more